Balancing influence between actors in healthcare decision making

Area of Science:

• Health Services Research
• Health Economics
• Public Health Policy

Background:

• Healthcare costs are not consistently linked to improved patient or public health outcomes in developed nations.
• The U.S. healthcare system exhibits significant variations in access, high costs, and suboptimal population health.
• Existing healthcare reform legislation in the U.S. offers only partial solutions to these systemic issues.

Purpose of the Study:

• To analyze the misalignment of incentives within healthcare systems that hinders the maximization of population health.
• To examine the competing interests of individuals, healthcare enterprises, and government actors.
• To propose necessary changes for aligning healthcare structures and incentives to prioritize population health outcomes.

Main Methods:

• Analysis of the healthcare market through a simplified model of actor motivations (individuals, enterprises, government).
• Evaluation of the current balance of power and information control among healthcare actors.
• Consideration of Pareto efficiency in the context of healthcare market dynamics.

Main Results:

• Healthcare systems are characterized by misaligned incentives, where enterprises and government actors often have competing interests with individuals.
• The failure to implement effective preventive interventions exemplifies this incentive misalignment.
• A significant shift in the healthcare market necessitates substantial changes in the motivations and utilities of enterprise and government actors.

Conclusions:

• Maximizing population health requires a re-evaluation of the balance of power and incentives among healthcare stakeholders.
• Key actions include enhancing transparency in medical decision-making and patient involvement.
• Strengthening the government's role as a public advocate and regulating direct-to-consumer advertising are essential.